AVEO to present tivozanib preclinical data, monoclonal antibody pipeline at AACR meeting
Links shared publicly online about this topic.
- 406total visits
AVEO to present tivozanib preclinical data, monoclonal antibody pipeline at AACR meeting
AVEO Pharmaceuticals, Inc. today announced that preclinical data on tivozanib, AVEO's lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, and the company's monoclonal antibody pipeline will be presented during poster sessions at the American Association for Cancer Research 102nd Annual Meeting 2011 being held April 2-6, 2011 in Orlando, Fla.
View full resource at news-medical.net
Tags: Cancer, Pharma, Oncology, News
Most Recently Shared on March 28, 2011 at 3:19 pm By:
Oncology News: AVEO to present tivozanib preclinical data, monoclonal antibody pipeline at AACR meeting: AVEO Ph... http://bit.ly/g0pgcu
Advertisement
